Open navigation
Search
Associate

Pierre Maunand

Languages
  • French
  • English
Social media

Pierre Maunand joined the Capital Markets team of CMS Francis Lefebvre in 2018, after having assisted the team during a six-month internship.

He advises corporate clients and financial institutions on capital market transactions, notably with respect to debt offerings (plain-vanilla and structured bond issuances, EMTN and CP programmes, covered bonds, debt restructuring and liability management transactions), share equity and equity-linked products (initial public offerings, preferred shares, convertible and exchangeable bonds, warrants, certificates, secondary offerings) and structured derivatives with an emphasis on equity derivatives transactions.

Memberships & Roles

  • Bar of Hauts-de-Seine

Education

  • CAPA (2018)
  • Master's degree in Banking and Financial Law – University Paris II Panthéon Assas (2017)
  • Master's degree in Business Law – University Paris V Descartes (2016)
Practice Areas

Further reading

Insights by Pierre

CMS Francis Lefebvre advises GenSight Biologics on its second fundraising in 2026

CMS Francis Lefebvre advises GenSight Biologics on its second fundraising in 2026

26 Oct 2026 1 min read
CMS Francis Lefebvre advises GenSight Biologics on a first fundraising in 2026

CMS Francis Lefebvre advises GenSight Biologics on a first fundraising in 2026

31 Mar 2026 1 min read
US private placement for Fagron: CMS and Morgan Lewis advise PGIM on the deal

US private placement for Fagron: CMS and Morgan Lewis advise PGIM on the deal

02 Dec 2025 2 min read
Capital increase of Innate Pharma reserved to IFL

Capital increase of Innate Pharma reserved to IFL

23 Dec 2024 2 min read
Back to top Back to top
Opens in new window